Perspective Therapeutics, Inc. (CATX)
3.18
-0.12
(-3.64%)
USD |
NYAM |
Aug 24, 16:00
3.18
0.00 (0.00%)
After-Hours: 20:00
Perspective Therapeutics Shareholders Equity (Quarterly) : 323.86M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 323.86M |
| March 31, 2026 | 347.44M |
| December 31, 2025 | 207.03M |
| September 30, 2025 | 242.22M |
| June 30, 2025 | 265.69M |
| March 31, 2025 | 284.64M |
| December 31, 2024 | 290.67M |
| September 30, 2024 | 328.47M |
| June 30, 2024 | 341.00M |
| March 31, 2024 | 229.89M |
| December 31, 2023 | |
| September 30, 2023 | 98.77M |
| June 30, 2023 | 108.65M |
| March 31, 2023 | 118.03M |
| June 30, 2022 | 61.28M |
| March 31, 2022 | 63.20M |
| December 31, 2021 | 64.39M |
| September 30, 2021 | 65.76M |
| June 30, 2021 | 67.41M |
| March 31, 2021 | 68.10M |
| December 31, 2020 | 12.77M |
| September 30, 2020 | 5.095M |
| June 30, 2020 | 5.723M |
| March 31, 2020 | 5.818M |
| December 31, 2019 | 6.141M |
| Date | Value |
|---|---|
| September 30, 2019 | 6.955M |
| June 30, 2019 | 7.68M |
| March 31, 2019 | 8.611M |
| December 31, 2018 | 9.665M |
| September 30, 2018 | 11.11M |
| June 30, 2018 | 5.03M |
| March 31, 2018 | 6.616M |
| December 31, 2017 | 7.871M |
| September 30, 2017 | 9.146M |
| June 30, 2017 | 10.60M |
| March 31, 2017 | 12.25M |
| December 31, 2016 | 13.57M |
| September 30, 2016 | 14.97M |
| June 30, 2016 | 16.40M |
| March 31, 2016 | 17.52M |
| December 31, 2015 | 18.55M |
| September 30, 2015 | 19.84M |
| June 30, 2015 | 20.78M |
| March 31, 2015 | 21.60M |
| December 31, 2014 | 22.53M |
| September 30, 2014 | 23.42M |
| June 30, 2014 | 23.96M |
| March 31, 2014 | 24.65M |
| December 31, 2013 | 6.489M |
| September 30, 2013 | 7.415M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 137.28M |
| MiMedx Group, Inc. | 216.00M |
| ABVC BioPharma, Inc. | 10.29M |
| Enovis Corp. | 1.477B |
| Edwards Lifesciences Corp. | 10.62B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 392.02M |
| Total Liabilities (Quarterly) | 68.16M |
| Debt to Equity Ratio | 0.0122 |
| Current Ratio | 6.609 |
| Net Debt Paydown Yield | -0.01% |